REGINfo: MSI - Financial information

SEARCH BY

Issuer directory

KEYWORDS

COMPANIES / ISIN

TYPE OF INFORMATION

INDUSTRY

ADVANCED SEARCH

COMPARTMENTS / INDICES

France

America

Asia

Oceania

> ASX 20
Australia - ASX 20
> NZX 15
New Zealand - NZX 15

Africa

> FTSE/JSE...
South Africa - FTSE/JSE Top 40
- Remgro
- RICHEMONT
- RMB Holdings
- Sanlam
- Sasol
- Shoprite
- Standard Bank Group
- Tiger Brands
- Vodacom Group
- WOOLWORTHS
> TA 25
Israel - TA 25
- AVNER OIL
- AZRIELI GROUP
- BEZEQ
- DELEK DRILLIN
- DISCOUNT
- ELBIT SYSTEMS
- FIBI BANK
- GAZIT GLOBE
- ICL
- IFF
- ISRAEL CORP
- KENON
- LEUMI
- MIGDAL INSURANCE
- MIZRAHI TEFAHOT
- NICE
- OPKO HEALTH
- OSEM
- PAZ OIL
- PERRIGO
- POALIM
- STRAUSS GROUP
- TEVA

Europe

INDEX SEARCH RESULT

2020.01.16 | 09:00 | Permanent Information Releases / General Company News

NOVARTIS

puce Public-Private Collaboration Commits to Accelerate Access to Health Services in Africa, Reaching 1.7 Million People - HTML (w)

2020.01.14 | 07:20 | Permanent Information Releases / General Company News

ARYZTA AG

puce Planned Organisational Changes ARYZTA North America - HTML (w)

2020.01.13 | 17:55 | Permanent Information Releases / General Company News

ROCHE

puce Roche and Illumina partner to broaden patient access to genomic testing - HTML (w)

2020.01.09 | 05:00 | Permanent Information Releases / Sales and Revenues

SIKA

puce SIKA MIT UMSATZREKORD VON CHF 8.11 MILLIARDEN – STARKES WACHSTUM VON 16.3% - HTML (w)

2020.01.09 | 05:00 | Permanent Information Releases / Sales and Revenues

SIKA

puce SIKA ACHIEVES SALES RECORD OF CHF 8.11 BILLION – STRONG GROWTH OF 16.3% - HTML (w)

2020.01.06 | 18:05 | Permanent Information Releases / General Company News

NOVARTIS

puce Novartis successfully completes acquisition of The Medicines Company, adding a potentially first-in-class, investigational cholesterol-lowering therapy inclisiran - HTML (w)

2020.01.06 | 07:00 | Public offerings / Statement of purchases / sales

NOVARTIS

puce Novartis completes tender offer for all outstanding shares of The Medicines Company - HTML (w)

2019.12.30 | 17:48 | Share Buybacks / Share redemption programmes

NESTLE

puce Nestlé completes CHF 20 billion share buyback program, will start new share buyback program of up to CHF 20 billion - HTML (w)

2019.12.23 | 07:00 | Permanent Information Releases / General Company News

ROCHE

puce Roche enters licensing agreement with Sarepta Therapeutics to improve the lives of patients living with Duchenne muscular dystrophy - HTML (w)

2019.12.19 | 19:32 | Permanent Information Releases / General Company News

NESTLE

puce Nestlé to sell 60% stake of Herta and create a joint venture with Casa Tarradellas - HTML (w)

2019.12.19 | 07:00 | Permanent Information Releases / General Company News

ROCHE

puce European Commission approves Roche’s Kadcyla for the adjuvant treatment of people with HER2-positive early breast cancer with residual invasive disease after neoadjuvant treatment - HTML (w)

2019.12.19 | 07:00 | Permanent Information Releases / General Company News

CLARIANT

puce Clariant AG: Clariant has agreed to sell its Masterbatches business for approx. USD 1.6 billion - HTML (w)

2019.12.17 | 14:55 | Permanent Information Releases / General Company News

ROCHE

puce Roche concludes acquisition of Spark Therapeutics, Inc. to strengthen presence in gene therapy - HTML (w)

2019.12.17 | 07:00 | Share History / Voting Rights and Number of Shares

ROCHE

puce Roche purchases shares in tender offer for Spark Therapeutics, Inc. - HTML (w)

2019.12.16 | 23:55 | Permanent Information Releases / General Company News

ROCHE

puce Roche and Spark Therapeutics, Inc. announce closing of investigation and unconditional clearance by the FTC and expiration of Hart-Scott-Rodino waiting period for acquisition of Spark Therapeutics, Inc - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 1000